Lysine [K] methyltransferase 2A (KMT2A, previously known as MLL) gene rearrangements are common in various subtypes of acute leukemia and are related to chemotherapy refractoriness and adverse prognosis [1]. This evidence concerns the gene KMT2A and acute leukemia.